LifeStance Health Group, Inc. (NASDAQ:LFST) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six brokerages that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, three have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $8.30.

Several research analysts have weighed in on the company. William Blair reaffirmed an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. Canaccord Genuity Group started coverage on shares of LifeStance Health Group in a research report on Thursday, April 3rd. They set a "buy" rating and a $8.00 price target on the stock. Finally, KeyCorp initiated coverage on shares of LifeStance Health Group in a research note on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price objective on the stock.

LifeStance Health Group Trading Up 0.6 %

LifeStance Health Group stock opened at $6.53 on Monday. The company has a market cap of $2.51 billion, a price-to-earnings ratio of -25.12 and a beta of 1.30. The firm has a 50-day moving average of $6.99 and a 200-day moving average of $7.31. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. LifeStance Health Group has a one year low of $4.64 and a one year high of $8.61.

Insider Activity at LifeStance Health Group

In related news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the completion of the sale, the insider now directly owns 339,810 shares of the company's stock, valued at approximately $2,344,689. This trade represents a 5.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 6.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On LifeStance Health Group

Hedge funds and other institutional investors have recently modified their holdings of the company. Blue Trust Inc. raised its stake in LifeStance Health Group by 124.4% in the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock worth $27,000 after purchasing an additional 2,122 shares in the last quarter. R Squared Ltd bought a new position in LifeStance Health Group during the 4th quarter worth $80,000. Ameriprise Financial Inc. acquired a new position in LifeStance Health Group in the 4th quarter valued at $87,000. Cibc World Markets Corp acquired a new stake in shares of LifeStance Health Group during the 4th quarter worth $96,000. Finally, Forum Financial Management LP bought a new position in shares of LifeStance Health Group in the fourth quarter worth $110,000. Institutional investors and hedge funds own 85.50% of the company's stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.